This study analyzed news coverage from the Indianapolis Star and The New York Times about the blockbuster drug Prozac® from the day it was approved on Dec. 29, 1987, until Dec. 31, 2006, to gain insights about whether the tone and prominence of news stories about Prozac changed over the duration of its 20 year lifecycle.A content analysis was used to evaluate whether stories were more favorable in tone during the first phase of Prozac's lifecycle, whether the tone of those stories became more negative as time passed, and, if it did, during which phase of Prozac's lifecycle that change in tone occurred.The findings from this study can assist public relations practitioners - particularly those who work in the pharmaceutical industry - in deve...
Recent social and legal responses to novel psychoactive drugs (NPDs) have been attributed to media p...
Background: Previous analyses of the listings of trastuzumab on the Australian Pharmaceutical Benefi...
In 2003-2004 and 2007-2008, the regulatory banning of SSRI use in pediatrics and young adults due to...
Objectives:There are multifaceted views on the use of ketamine, a potentially addictive substance, t...
OBJECTIVES:There are multifaceted views on the use of ketamine, a potentially addictive substance, t...
Objective: to determine the frequency and nature of news stories of prescription drugs in a range of...
This is the author accepted manuscript. The final version is available from BMJ Publishing Group via...
[Background] Following a nationwide switch to a generic antidepressant, a series of negative media s...
The oncology market represents one of the largest pharmaceutical markets in any medical field, and p...
Background: The news media are an important source of information about new medical treatments, but ...
OBJECTIVES Since the first reporting of ketamine's antidepressant effects in 2000, there has been g...
This dissertation examined how the news media covered the Opioid Crisis of the 21st century compared...
BACKGROUND: The oncology market represents one of the largest pharmaceutical markets in any medical ...
This study investigates media coverage of the re-evaluation process of glyphosate from 1 January 201...
In the 1990s the estimated prevalence of depression was two thousand times higher than in the 1960s ...
Recent social and legal responses to novel psychoactive drugs (NPDs) have been attributed to media p...
Background: Previous analyses of the listings of trastuzumab on the Australian Pharmaceutical Benefi...
In 2003-2004 and 2007-2008, the regulatory banning of SSRI use in pediatrics and young adults due to...
Objectives:There are multifaceted views on the use of ketamine, a potentially addictive substance, t...
OBJECTIVES:There are multifaceted views on the use of ketamine, a potentially addictive substance, t...
Objective: to determine the frequency and nature of news stories of prescription drugs in a range of...
This is the author accepted manuscript. The final version is available from BMJ Publishing Group via...
[Background] Following a nationwide switch to a generic antidepressant, a series of negative media s...
The oncology market represents one of the largest pharmaceutical markets in any medical field, and p...
Background: The news media are an important source of information about new medical treatments, but ...
OBJECTIVES Since the first reporting of ketamine's antidepressant effects in 2000, there has been g...
This dissertation examined how the news media covered the Opioid Crisis of the 21st century compared...
BACKGROUND: The oncology market represents one of the largest pharmaceutical markets in any medical ...
This study investigates media coverage of the re-evaluation process of glyphosate from 1 January 201...
In the 1990s the estimated prevalence of depression was two thousand times higher than in the 1960s ...
Recent social and legal responses to novel psychoactive drugs (NPDs) have been attributed to media p...
Background: Previous analyses of the listings of trastuzumab on the Australian Pharmaceutical Benefi...
In 2003-2004 and 2007-2008, the regulatory banning of SSRI use in pediatrics and young adults due to...